Innovative approach We have the backing of scientific endorsements and clinical studies.
Managing Insulin Sensitivity: HRT may help improve insulin sensitivity, reducing the risk of insulin resistance and the associated abdominal fat gain
13 The vitamin D receptor plays a crucial role in regulating several physiological processes, such as cell growth, immune system function, calcium balance, and inflammation in the human body

Ozempic vs Saxenda: Switching Between Them Safely At a glance Drug class / Both are GLP-1 receptor agonists acting on the same receptor Ozempic dosing / Once-weekly subcutaneous injection, 0.25 mg titrated to 0.5, 1.0, or 2.0 mg Saxenda dosing / Once-daily subcutaneous injection, titrated from 0.6 mg to 3.0 mg over 4-5 weeks SUSTAIN-7 weight loss / Semaglutide 1.0 mg produced 5.5-7.3 kg loss at 40 weeks in type 2 diabetes SCALE trial weight loss / Liraglutide 3.0 mg produced 8.0% mean body weight loss at 56 weeks FDA indication for Ozempic / Type 2 diabetes (weight loss is off-label at current doses) FDA indication for Saxenda / Chronic weight management in adults with BMI 30 or 27 with comorbidity Switching protocol / Stop one agent, begin the new agent at the lowest titration dose Common switch reason / GI intolerance, insufficient efficacy, or insurance coverage changes No washout required / Both drugs target the GLP-1 receptor, so no washout period is needed before switching How Ozempic and Saxenda Compare Head to Head Both Ozempic and Saxenda activate the GLP-1 receptor, but they are different molecules with distinct pharmacokinetic profiles
